← Leaderboards
Kristin Gail Anderson
University Of Virginia
$565,660
Attributed
$565,660
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $192.2K · FY2023–25$200K$150K$100K$50K$0
'23
'24
'25
Funding mix
By agency
NIH$565,660 · 1
By mechanism
K22$565,660 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Virginia
Same institution · by research overlap
- Thomas P Loughran$27,014,958
- Jonathan R Lindner$23,863,903
- Eric R Houpt$18,307,652
- Antonio Abbate$5,930,239
- Mete Civelek$6,209,985
Others in their field
Other Rising Stars on “Clinically Relevant”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Walt Lee$17,139,099
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Heinz Ernst Moser · University Of Texas Med Br Galveston$12,973,432
- John Alam · Eip Pharma, Inc.$10,411,018
- Songthip T. Ounpraseuth · Univ Of Arkansas For Med Scis$10,363,762
Research focus
Clinically RelevantAffinityAdoptive Cell TransfersAnti-CancerAntigensAntigen TargetingAntibodiesAdoptive TransferAutoantigensAutologousBlocking AntibodiesCancer CellCancer Cell LineCancer Infiltrating T CellsCancer TypeCd8-Positive T-LymphocytesCell Culture TechniquesCell LineCell PhysiologyCellsChemotherapyChimeric Antigen ReceptorClinical DevelopmentCytokine
Grant awards (3)
Engineering T cells to overcome inhibitory receptor signals that limit the efficacy of adoptive cell therapy against ovarian cancer$186,710
K22 · FY2025 · CA · contact PI
Engineering T cells to overcome inhibitory receptor signals that limit the efficacy of adoptive cell therapy against ovarian cancer$186,710
K22 · FY2024 · CA · contact PI
Engineering T cells to overcome inhibitory receptor signals that limit the efficacy of adoptive cell therapy against ovarian cancer$192,240
K22 · FY2023 · CA · contact PI